KNOCKDOWN Trademark

Trademark Overview

On Friday, August 2, 2002, a trademark application was filed for KNOCKDOWN with the United States Patent and Trademark Office. The USPTO has given the KNOCKDOWN trademark a serial number of 76437732. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, September 24, 2003. This trademark is owned by Atugen AG. The KNOCKDOWN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research services in functional genomics for use in genetic analysis, antisense technology, target validation, improved therapeutics, and drug development
knockdown

General Information

Serial Number76437732
Word MarkKNOCKDOWN
Filing DateFriday, August 2, 2002
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, September 24, 2003
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesResearch services in functional genomics for use in genetic analysis, antisense technology, target validation, improved therapeutics, and drug development
Pseudo MarkKNOCK DOWN

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, August 28, 2002
Primary Code042
First Use Anywhere DateSunday, June 24, 2001
First Use In Commerce DateSunday, June 24, 2001

Trademark Owner History

Party NameAtugen AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
Address13125 Berlin
DE

Trademark Events

Event DateEvent Description
Wednesday, September 24, 2003ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, January 13, 2003NON-FINAL ACTION MAILED
Wednesday, December 11, 2002ASSIGNED TO EXAMINER

Related Keywords

knockdown validation target improved therapeutics development drug technology antisense functional services